How should proteinuria be detected and measured?

被引:190
作者
Lamb, Edmund J. [1 ]
MacKenzie, Finlay [3 ]
Stevens, Paul E. [2 ]
机构
[1] Kent & Canterbury Hosp, E Kent Hosp Univ NHS Fdn Trust, Dept Clin Biochem, Canterbury CT1 3NG, Kent, England
[2] E Kent Hosp Univ NHS Fdn Trust, Dept Renal Med, Canterbury CT1 3NG, Kent, England
[3] Wolfson EQA Lab, Birmingham B15 2UE, W Midlands, England
关键词
CHRONIC KIDNEY-DISEASE; COOMASSIE BRILLIANT BLUE; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; BLOOD-PRESSURE CONTROL; CREATININE RATIO; CARDIOVASCULAR RISK; CEREBROSPINAL-FLUID; HYPERTENSIVE DISORDERS; DIPSTICK PROTEINURIA;
D O I
10.1258/acb.2009.009007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Proteinuria is a classic sign of kidney disease and its presence carries powerful prognostic information. Although proteinuria testing is enshrined in clinical practice guidelines, there is surprising variation among such guidelines as to the definition of clinically significant proteinuria. There is also poor agreement as to whether proteinuria should be defined in terms of albumin or total protein loss, with a different approach being used to stratify diabetic and non-diabetic nephropathy. Further, the role of reagent strip devices in the detection and assessment of proteinuria is unclear. This review explores these issues in relation to recent national and international guidelines on chronic kidney disease (CKD) and epidemiological evidence linking proteinuria and clinical outcome. The authors argue that use of urinary albumin measurement as the front-line test for proteinuria detection offers the best chance of improving the sensitivity, quality and consistency of approach to the early detection and management of CKD.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 106 条
[1]   Dipstick proteinuria: Can it guide hypertension management? [J].
Agarwal, R ;
Panesar, A ;
Lewis, RR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (06) :1190-1195
[2]  
[Anonymous], DIAGN MAN CHRON KIDN
[3]  
[Anonymous], CHRON KIDN DIS AD UK
[4]  
[Anonymous], CHRON KIDN DIS NAT C
[5]   UK consensus conference on early chronic kidney disease - 6 and 7 February 2007 [J].
Archibald, G. ;
Bartlett, W. ;
Brown, A. ;
Christie, B. ;
Elliott, A. ;
Griffith, K. ;
Pound, S. ;
Rappaport, I. ;
Robertson, D. ;
Semple, Y. ;
Slane, P. ;
Whitworth, C. ;
Williams, B. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (09) :2455-2457
[6]   Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[7]   Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].
Asselbergs, FW ;
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Janssen, WMT ;
Voors, AA ;
de Zeeuw, D ;
de Jong, PE ;
van Veldhuisen, DJ ;
van Gilst, WH .
CIRCULATION, 2004, 110 (18) :2809-2816
[8]   Association between albuminuria and proteinuria in the general population: the AusDiab Study [J].
Atkins, RC ;
Briganti, EM ;
Zimmet, PZ ;
Chadban, SJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :2170-2174
[9]   URINE ALBUMIN SHOULD REPLACE TOTAL PROTEIN FOR THE ASSESSMENT OF GLOMERULAR PROTEINURIA [J].
BALLANTYNE, FC ;
GIBBONS, J ;
OREILLY, DSJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 1993, 30 :101-103
[10]   EFFECT OF AGGREGATES ON ALBUMIN STANDARDIZATION [J].
BLAABJERG, O ;
PETERSEN, PH .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1979, 39 (08) :751-757